临床研究
Copyright ©The Author(s) 2025.
世界华人消化杂志. 2025-05-28; 33(5): 373-380
在线出版 2025-05-28. doi: 10.11569/wcjd.v33.i5.373
表4 化疗预后的影响因素分析
变量βS.E.Wald χ2OR95%CIP
模型1
肿瘤直径0.7830.22312.3322.1881.593-3.006<0.001
临床分期
Ⅲ期1.000
Ⅳ期1.7190.41017.5775.5792.045-15.218<0.001
淋巴结转移
1.000
1.8190.42418.4126.1682.186-17.402<0.001
PIV0.7540.20513.5172.1251.627-2.775<0.001
FAR0.6640.18512.8851.9431.503-2.511<0.001
CONUT评分0.5850.17211.5621.7951.383-2.329<0.001
常数项--<0.001
模型2
PIV0.6870.19013.0671.9871.511-2.614<0.001
FAR0.6090.19210.0731.8391.428-2.369<0.001
CONUT评分0.5070.15810.2951.6601.302-2.117<0.001
常数项--<0.001

引文著录: 钟彩琼, 张宁波, 朱剑. PIV、FAR联合CONUT评分预测结直肠癌患者化疗预后的研究. 世界华人消化杂志 2025; 33(5): 373-380